BridgeMD
New treatment option for Peri-implantitis
Official title Peri-implantitis Treatment With Chitosan Brush
ClinicalTrials.gov ID: NCT06830200
What this study is testing
- What it's testing
- In dentistry, dental implant applications for tooth loss/deficiency are prominent and provide successful long-term results in terms of functionality and aesthetics. However, peri-implant diseases such as peri-implant mucositis and peri-implantitis may develop due to biofilm accumulation around the implant.
- Time commitment: about 12 months
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Presence of peri-implantitis in an implant that has been in function for more than 12 months
- Age ≥ 18 and \< 65
- Agreeing to participate in the study after reading the informed consent form
- Completion of periodontal treatment of patients diagnosed with periodontitis before inclusion in the study
You likely can't join if
- Patients under 18 years of age
- Patients who have received or are currently receiving radiotherapy, chemotherapy and long-term systemic corticosteroid treatment
- Patients who received systemic antibiotics within 6 months from baseline
- Pregnant or lactating patients
- Patients with anatomical abnormalities around the implant (e.g., apically positioned implants adjacent to a tooth)
- Patients with prostheses that prevent access for implant debridement with chitosan brushes or titanium curettes
See the full eligibility criteria
- Presence of peri-implantitis in an implant that has been in function for more than 12 months
- Age ≥ 18 and \< 65
- Agreeing to participate in the study after reading the informed consent form
- Completion of periodontal treatment of patients diagnosed with periodontitis before inclusion in the study
- Patients under 18 years of age
- Patients who have received or are currently receiving radiotherapy, chemotherapy and long-term systemic corticosteroid treatment
- Patients who received systemic antibiotics within 6 months from baseline
- Pregnant or lactating patients
- Patients with anatomical abnormalities around the implant (e.g., apically positioned implants adjacent to a tooth)
- Patients with prostheses that prevent access for implant debridement with chitosan brushes or titanium curettes
- Implants with an overdenture superstructure
- Implants to be explanted
- Patients with ASA score ≥ 3
- Patients reporting reactions or adverse events to chitosan, stainless steel, adhesives, or polypropylene
- Clinically mobile implants
- Recently placed and non-osseointegrated implants
- Around major nerves and blood vessels, if there is a risk of structural damage
The study team makes the final eligibility decision.
Where it's taking place
- Ankara, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 12 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ankara, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.